Latest goodwill for VIRI: $12M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), VIRI shows a goodwill of $12M. That compares with $12B in the prior-year period — down 99.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VIRI's goodwill is now $12M (was $12B) — a 99.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Virios Therapeutics is outperforming or lagging.
Tracking VIRI's goodwill over time shows whether Virios Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $12B in the prior-year period — down 99.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Virios Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $12M) with ownership activity and broader fundamentals.
Virios Therapeutics's goodwill is $12M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.